SCHEDULE 13G

Company

Celldex Therapeutics, Inc.

Filed

February 7, 2001

Accession Number

0001047469-01-000179

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →